Nebivolol Drug Study
Nebivolol Drug Study
Nebivolol Drug Study
Name: Alteah Michaella V. Mintu Group/Section: Group 14 Preceptor/CI: Ma’am Princess S. Tantoco Date: September 26, 2023
DRUG NAME INDICATION MECHANISM OF ACTION CONTRAINDICATION ADVERSE EFFECTS NURSING RESPONSIBILTY
Nebivolol is a combination
of equivalent amounts of Nebivolol is used Observe the ECG closely when the dose is
Drug Name: Nebivolol two substances with independently or with other Nebivolol is changed or given intravenously. Aside
Nebivolol may compel
dissymmetric molecular medications to treat contraindicated in from that, monitor the patient’s vital signs
some individuals to
Class: Beta-blocker structures that mirror one hypertension. It relaxes blood patients with Child-Pugh and for any toxicity or adverse reactions
become less attentive
another, a mixture of 2 vessels and slows heart rate to class C hepatic the patient may feel. Monitor the patient
than they usually are.
Dosage & Route: enantiomers. It acts as a improve blood flow and lower impairment for wheezes if they develop asthma due to
2.5 mg orally once a day cardiac stimulant without blood pressure. beta-blocker therapy.
beta-adrenergic activity.
School of Nursing and Allied Health Studies
DRUG NAME INDICATION MECHANISM OF ACTION CONTRAINDICATION ADVERSE EFFECTS NURSING RESPONSIBILTY
Drug Name:
Class:
DRUG NAME INDICATION MECHANISM OF ACTION CONTRAINDICATION ADVERSE EFFECTS NURSING RESPONSIBILTY
Drug Name:
Class:
DRUG NAME INDICATION MECHANISM OF ACTION CONTRAINDICATION ADVERSE EFFECTS NURSING RESPONSIBILTY
Drug Name:
Class: